List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #19,941 to #19,990.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Epoxides → Epoxide
  2. Epoxy resin → Epoxy
  3. Epoxy resins → Epoxy
  4. Epoöphoron → Epoophoron
  5. Eprosartan adverse reactions → Eprosartan#Adverse Reactions
  6. Eprosartan clinical pharmacology → Eprosartan#Pharmacology
  7. Eprosartan contraindications → Eprosartan#Contraindications
  8. Eprosartan description → Eprosartan#Pharmacology
  9. Eprosartan dosage and administration → Eprosartan#Adult Indications and Dosage
  10. Eprosartan drug interactions → Eprosartan#Drug Interactions
  11. Eprosartan how supplied storage and handling → Eprosartan#How Supplied
  12. Eprosartan indications and usage → Eprosartan#Adult Indications and Dosage
  13. Eprosartan labels and packages → Eprosartan#Package and Label Display Panel
  14. Eprosartan nonclinical toxicology → Eprosartan#Nonclinical Toxicology
  15. Eprosartan overdosage → Eprosartan#Overdosage
  16. Eprosartan use in specific populations → Eprosartan#Use in Specific Populations
  17. Eprosartan warnings and precautions → Eprosartan#Warnings
  18. Epsilon rays → Epsilon radiation
  19. Epsilon waves → Epsilon wave
  20. Epsom Salt → Magnesium
  21. Epsom salt → Magnesium sulfate
  22. Epsom salts → Magnesium sulfate
  23. Epstein-Barr → Epstein Barr virus
  24. Epstein-Barr Virus → Epstein Barr virus
  25. Epstein-Barr virus → Epstein Barr virus
  26. Epstein-Barr virus infection → Epstein Barr virus
  27. Epstein-Goedel syndrome → Essential thrombocytosis
  28. Epstein-barr virus → Epstein Barr virus
  29. Epstein barr virus mononucleosis → Mononucleosis
  30. Epstein–Barr virus → Epstein Barr virus
  31. Epstien-Barr Virus → Epstein Barr virus
  32. Eptacog alfa → Recombinant factor VIIa
  33. Eptal → Phenytoin
  34. Eptifibatide: Result of EVA-AMI Trial Released → Special:Badtitle/NS100:Eptifibatide: Result of EVA-AMI Trial Released
  35. Eptifibatide: Results of BRIEF-PCI Trial Released → Special:Badtitle/NS100:Eptifibatide: Results of BRIEF-PCI Trial Released
  36. Eptifibatide adverse reactions → Eptifibatide#Adverse Reactions
  37. Eptifibatide clinical pharmacology → Eptifibatide#Pharmacology
  38. Eptifibatide clinical studies → Eptifibatide#Clinical Studies
  39. Eptifibatide contraindications → Eptifibatide#Contraindications
  40. Eptifibatide description → Eptifibatide#Structure
  41. Eptifibatide detailed information → Eptifibatide#Pharmacology
  42. Eptifibatide dosage and administration → Eptifibatide#Adult Indications and Dosage
  43. Eptifibatide dosage forms and strengths → Eptifibatide#How Supplied
  44. Eptifibatide drug interactions → Eptifibatide#Drug Interactions
  45. Eptifibatide how supplied → Eptifibatide#How Supplied
  46. Eptifibatide how supplied storage and handling → Eptifibatide#How Supplied
  47. Eptifibatide indications → Eptifibatide#Adult Indications and Dosage
  48. Eptifibatide indications and usage → Eptifibatide#Adult Indications and Dosage
  49. Eptifibatide instructions for administration → Eptifibatide#Administration and Monitoring
  50. Eptifibatide labels and packages → Eptifibatide#Package and Label Display Panel

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"